These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26328949)

  • 21. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computation of the physio-chemical properties and data mining of large molecular collections.
    Cheng A; Diller DJ; Dixon SL; Egan WJ; Lauri G; Merz KM
    J Comput Chem; 2002 Jan; 23(1):172-83. PubMed ID: 11913384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors.
    Yousuf M
    Curr Cancer Drug Targets; 2019; 19(11):906-918. PubMed ID: 30894110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In-silico prediction of pharmacokinetic properties].
    Hashida M
    Yakugaku Zasshi; 2005 Nov; 125(11):853-61. PubMed ID: 16272806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
    Ekins S; Boulanger B; Swaan PW; Hupcey MA
    Mol Divers; 2002; 5(4):255-75. PubMed ID: 12549676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
    Ekins S; Boulanger B; Swaan PW; Hupcey MA
    J Comput Aided Mol Des; 2002; 16(5-6):381-401. PubMed ID: 12489686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.
    Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM
    Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico prediction of ADME properties: are we making progress?
    Beresford AP; Segall M; Tarbit MH
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. truPK -- human pharmacokinetic models for quantitative ADME prediction.
    Subramanian K
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADME-Space: a new tool for medicinal chemists to explore ADME properties.
    Bocci G; Carosati E; Vayer P; Arrault A; Lozano S; Cruciani G
    Sci Rep; 2017 Jul; 7(1):6359. PubMed ID: 28743970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of pharmacokinetic parameters.
    Madan AK; Dureja H
    Methods Mol Biol; 2012; 929():337-57. PubMed ID: 23007436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systems Pharmacology in Small Molecular Drug Discovery.
    Zhou W; Wang Y; Lu A; Zhang G
    Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
    Tsaioun K; Blaauboer BJ; Hartung T
    ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-silico ADME models: a general assessment of their utility in drug discovery applications.
    Gleeson MP; Hersey A; Hannongbua S
    Curr Top Med Chem; 2011; 11(4):358-81. PubMed ID: 21320065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity.
    Ekins S; Nikolsky Y; Nikolskaya T
    Trends Pharmacol Sci; 2005 Apr; 26(4):202-9. PubMed ID: 15808345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving molecules using multi-objective optimization: applying to ADME/Tox.
    Ekins S; Honeycutt JD; Metz JT
    Drug Discov Today; 2010 Jun; 15(11-12):451-60. PubMed ID: 20438859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.